[1]
“Stimulated adverse drug reaction reporting in pharmacovigilance: Indian perspectives”, jpadr, vol. 2, no. 2, pp. 13–18, Jun. 2021, Accessed: Nov. 12, 2026. [Online]. Available: https://jpadr.com/index.php/jpadr/article/view/29